Muutke küpsiste eelistusi

E-raamat: Signal Transduction and Human Disease

4.33/5 (6 hinnangut Goodreads-ist)
Edited by (National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA), Edited by (National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, USA)
  • Formaat: PDF+DRM
  • Ilmumisaeg: 18-Jul-2003
  • Kirjastus: Wiley-Liss Inc.,U.S.
  • Keel: eng
  • ISBN-13: 9780471448372
Teised raamatud teemal:
  • Formaat - PDF+DRM
  • Hind: 235,82 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Raamatukogudele
Signal Transduction and Human DiseaseSuurem pilt
  • Formaat: PDF+DRM
  • Ilmumisaeg: 18-Jul-2003
  • Kirjastus: Wiley-Liss Inc.,U.S.
  • Keel: eng
  • ISBN-13: 9780471448372
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This book uniquely relates the broad impact of signal transduction research on the understanding and treatment of human disease. There have been significant advances in the area of signaling in disease processes, yet no resource presently connects these advances with understanding of disease processes and applications for novel therapeutics. Given the emphasis on translational research and biological relevance in biotechnology, and, conversely, the importance of molecular approaches for clinical research, it is evident that a single resource bridging signaling research and human disease will be invaluable.

Arvustused

"The book is attractively laid out with clear, well-labeled figures and charts" (Journal of Natural Products, March 2005) "...the overall worth of the book is in the excellent job it does of taking readers from the etiology and management of the disease to our current understanding of the molecular mechanisms involved." (Quarterly Review of Biology, March-May 2005)

a successful workserves as a short summarising overview (Signal Transduction, No.1 2, 2004)

"...appropriate for a textbook...pathways and their regulation are well explained and there are helpful tables and illustrations. The information is current and is well referenced...Finkel, Gutkind, and their coauthors have put together examples that illustrate the growing depth of understanding the roles of signal transduction in disease..." (Cell, January 9, 2004)

...provides a sweeping look at current information derived from assessing the role of some kinases and phosphases on human conditions associated with disease...the book contains thoughtful, well-planned chapters...with extensive citations and excellent artwork...extremely valuable. (Pharmaceutical Research, Vol. 20, No. 12, December 2003)

Acknowledgments.
Contributors.
Introduction.
1. Atherosclerosis: Signal Transduction by Oxygen and Nitrogen Radicals (J. Hill, et al.).
2. NF-κB: A Key Signaling Pathway in Asthma (S. Levine).
3. Molecular Mechanisms of Cancer (A. Sodhi, et al.


Dr. Toren Finkel is Chief of the Cardiovascular Branch, National Heart Lung and Blood Institute, National Institutes of Health (NIH, DHHS). He received his undergraduate training in physics and then completed a combined M.D./Ph.D. program at Harvard Medical School. Following graduation he pursued an internal medical residency at the Massachusetts General Hospital in Boston and a Cardiology Fellowship at Johns Hopkins School of Medicine in Baltimore. His laboratory has been interested in the role of oxidants as signaling molecules and the participation of free radicals in human disease. Dr. J. Silvio Gutkind is Chief of the Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH, DHHS). He received his Ph.D. in pharmacy and biochemistry from the University of Buenos Aires, Argentina. His laboratory has addressed the molecular basis of cancer by studying normal and aberrant functions of molecules involved in the transduction of proliferative signals. He also leads a multi-institutional effort aimed to elucidate the molecular changes that contribute to the evolution of squamous cell carcinomas.
Lisainfo e-raamatute kohta Lisainfo e-raamatute kohta
Püsilink: https://www.kriso.ee/db/97804714483722e.html
Märksõnad: